IP Library Granted Patent US 10,214,771
Granted Patent B2
US 10,214,771 · App. 15/229,965 · Granted Feb 26, 2019

DNA amplification and sequencing using DNA molecules generated by random fragmentation

Inventors: Vladimir L. Makarov (Ann Arbor, MI); Irina Sleptsova (Ann Arbor, MI); Emmanuel Kamberov (Ann Arbor, MI); Eric Bruening (Chelsea, MI)
Assignee: Takara Bio USA, Inc.
C12Q1/6855C12Q1/6844C12Q1/6846C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,214,771
App. No.
15/229,965
Granted
Feb 26, 2019
Kind
B2
Abstract

The present invention is directed to methods to prepare a DNA molecule or a plurality of DNA molecules by random fragmentation. In some embodiments, the present invention regards preparing a template for DNA sequencing by random fragmentation. In specific embodiments, the random fragmentation comprises chemical fragmentation, mechanical fragmentation, or enzymatic fragmentation. In further specific embodiments, a universal sequence is attached to the 3′ end of the DNA fragments, such as by ligation of an adaptor sequence or by homopolymeric tailing with terminal deoxynucleotidyltransferase. In other embodiments, a library is prepared with methods of the present invention.

Claims (17)

1. A method of preparing a population of DNA fragments, comprising:

(a) fragmenting a DNA molecule to produce DNA fragments;

(b) producing a homopolymer extension on 3′ ends of the DNA fragments; and

(c) amplifying a plurality of the fragments with a population of primers complementary to a known sequence in the DNA fragments and a population of primers comprising a region complementary to the homopolymer extension, wherein a portion of each primer in the population of primers comprising a region complementary to the homopolymer extension comprises a random sequence.

2. The method of claim 1 , wherein the fragmenting is mechanical, thermal, or chemical fragmentation.

3. The method of claim 2 , wherein the fragmentation is by hydrodynamic shearing, sonication, acid catalytic hydrolysis, alkaline catalytic hydrolysis, hydrolysis by metal ions, hydroxyl radicals, irradiation, or heating.

4. The method of claim 1 , wherein the homopolymer extensions are generated by terminal deoxynucleotidyltransferase.

5. The method of claim 1 , further comprising sequencing a plurality of the amplified fragments.

6. The method of claim 1 , wherein the portion of each primer in the population of primers comprising a region complementary to the homopolymer extension that comprises a random sequence is about 50% of the sequence of each primer.

7. The method of claim 1 , wherein the portion of each primer in the population of primers comprising a region complementary to the homopolymer extension that comprises a random sequence is about 40% of the sequence of each primer.

8. The method of claim 1 , wherein the portion of each primer in the population of primers comprising a region complementary to the homopolymer extension that comprises a random sequence is about 30% of the sequence of each primer.

9. The method of claim 1 , wherein the portion of each primer in the population of primers comprising a region complementary to the homopolymer extension that comprises a random sequence is about 20% of the sequence of each primer.

10. The method of claim 1 , wherein the portion of each primer in the population of primers comprising a region complementary to the homopolymer extension that comprises a random sequence is about 10% of the sequence of each primer.

11. The method of claim 1 , wherein the portion of each primer in the population of primers comprising a region complementary to the homopolymer extension that comprises a random sequence is about 5% of the sequence of each primer.

12. The method according to claim 1 , wherein the method comprises preparing a plurality of populations of DNA fragments from a plurality of DNA molecules.

13. The method according to claim 1 , wherein the DNA molecule is a cDNA molecule.

14. The method according to claim 13 , wherein the method further comprises reverse transcribing the cDNA molecule from an mRNA template.

Assignments (2)
MERGER Recorded Sep 19, 2017
From: RUBICON GENOMICS, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 043631/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2017
From: MAKAROV, VLADIMIR L.; SLEPTSOVA, IRINA; KAMBEROV, EMMANUEL; BRUENING, ERIC
To: RUBICON GENOMICS, INC.
Reel/Frame 042975/0197 →
Continuity (5)
Continuation 14450344 · Aug 4, 2014
Continuation 12697886 · Feb 1, 2010
Continuation 10293048 · Nov 13, 2002
Provisional Application 60338224 · Nov 13, 2001
Related Publication 20170037460A1 · Feb 9, 2017